Form 4: Vericel CFO Sells 5,000 Shares Under 10b5-1 Plan

Vericel Corp's Chief Financial Officer, Joseph Anthony Mara Jr., sold 5,000 shares of common stock for $40.5 per share under a pre-arranged 10b5-1 trading plan.

Summary

• Joseph Anthony Mara Jr., Chief Financial Officer of Vericel Corp (VCEL), reported a sale of common stock.
• The transaction involved the disposition of 5,000 shares of Vericel common stock.
• The shares were sold at a price of $40.5 per share.
• The sale was executed on May 7, 2026.
• Following this transaction, Mr. Mara beneficially owns 21,009 shares of Vericel common stock.
• The sale was conducted pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2025.
• The remaining beneficially owned shares include those acquired through the Issuer's 2015 Employee Stock Purchase Plan, which are exempt under Rule 16b-3(d) and Rule 16b-3(c).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While it's an insider sale, the execution under a pre-arranged 10b5-1 plan reduces the negative implications typically associated with insider selling, suggesting personal financial management rather than a reaction to new company-specific information.

Positives

• The sale was conducted under a Rule 10b5-1 trading plan, indicating it was pre-scheduled and not based on immediate, non-public information, which mitigates concerns about opportunistic insider selling.

Negatives

• A key executive, the Chief Financial Officer, reduced their direct ownership in the company by 5,000 shares.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that transactions executed under Rule 10b5-1 plans are a common practice for corporate executives to manage personal financial planning, diversify holdings, and avoid accusations of trading on material non-public information. Such plans allow insiders to pre-arrange sales or purchases at a future date.

Stakeholder Impact

• Shareholders: May observe a reduction in direct ownership by a key executive, though the 10b5-1 plan context generally mitigates significant concern.

Key Dates

Recommendation

This Form 4 filing details a routine insider stock sale executed under a pre-arranged 10b5-1 trading plan. Such transactions are typically for personal financial management and do not inherently signal a change in the company's fundamental outlook or performance. Therefore, it does not provide sufficient new information to warrant a change from a 'hold' recommendation based solely on this filing.

Keywords

Vericel, VCEL, Form 4, Insider Trading, Stock Sale, CFO, Joseph Mara, 10b5-1 Plan, Equity Transaction, Officer Transaction